Picture of Kobayashi Pharmaceutical logo

4967 — Kobayashi Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeLarge CapHigh Flyer

Table: Kobayashi Pharmaceutical - 9-MTH group results

Oct 30 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2019        Sep 30, 2018     Dec 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              117.79              115.77           173.00    
                   (+1.7 pct)          (+7.5 pct)       (+3.3 pct)  
  Operating           20.30               19.57            27.30    
                   (+3.7 pct)          (+14.1 pct)      (+3.8 pct)  
  Recurring           21.45               20.59            27.90    
                   (+4.2 pct)          (+21.2 pct)      (+1.9 pct)  
  Net                 15.25               13.77            19.00    
                   (+10.7 pct)         (+17.3 pct)      (+5.4 pct)  
  EPS              194.20 yen          174.23 yen       240.29 yen  
  EPS Diluted                          174.13 yen                   
  Ann Div                               66.00 yen        68.00 yen  
  -Q2 div           33.00 yen           31.00 yen                   
  -Q4 div                               35.00 yen        35.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T

Recent news on Kobayashi Pharmaceutical

See all news